chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea 4/28/11 that evening diarrhea and febrile on Fri 4/29/11 into 5/1/11 achy joints mainly in her fingers redness and swelling at site rash all over body.
My shot was Feb. 24th and I had the initial soreness that I typically get with any shot.  That soreness only lasted a few days.  On March 5th, my injection site started to hurt.  It was swollen and hot to the touch.  It was itchy and felt somewhat hard.  The first day of this it was really itchy, hot and painful.  I took 2 benadryl.  The next day it was not as itchy or hot.  Today is March 8th and the injection site is still sore but not as bad as it was.  No more itching or hotness.  I did not get a rash.
Myalgia, Nausea Vomiting, Fatigue Missed work following second dose secondary to above symptoms
Felt like I had the flu.  Fever 100.2 achy all over.  Took Advil and that helped with the fever.  Symptoms continued for about 30 hours
The day after vaccination the area was 2" raised, red and indurated. St became itchy and other similar lesion appeared. They look bruised after 24 hours. No vesicles.
Initial information received on 30-Oct-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves Adult female patient who experienced large surface area of redness and swelling at the injection site, still has tenderness when raising arm several weeks after injection and still has tenderness when raising arm several weeks after injection, while she received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot number, expiry date not reported. On an unknown date, patient developed a non-serious large surface area of redness and swelling at the injection site (vaccination site inflammation), still has tenderness when raising arm several weeks after injection (tenderness), still has tenderness when raising arm several weeks after injection (limb discomfort) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Lab data not reported. Final diagnosis was still has tenderness when raising arm several weeks after injection, still has tenderness when raising arm several weeks after injection and large surface area of redness and swelling at the injection site. It was not reported if the patient received a corrective treatment. The event outcome is reported as Unknown.
Patient called within last  week (yes, she just called now almost 6 months later) & stated arm was "very heavy & sore" immediately following vaccine & although it has gradually gotten better/improved, she does still have some discomfort.
Severe chills, diarrhea, nausea, body aches, muscle weakness, fainted and loss bowel function.
Patient complained of pain and swelling in upper arm left side.  Unable to move arm next day of receiving immunization (Tdap).  Mom took to ER and was treated with antibiotic for 7 days.  Arm at time of follow up visit (May 16, 2012) was fine without swelling, redness or lump under skin.  Immunization provider was not made aware of incident until May 16, 2012 during repeat visit at that particular school site.
In addition to "normal" symptoms, (fever, aching, sever headache, fatigue, body aches, bloating, water wight gain) racing heart, hard heart beats.  Slept 20 hours on 05/16/2021.  Sever chest pain.    Experienced jaw pain also.    Chest pain has persisted.  Much worse when laying down.  Gets better when sitting up.    As of today, still experiencing significant chest pain.    No chest pain previously.
Lightheadedness in the 5 minutes following the SARS Cove 2 vaccine #1 that rapidly progressed to lower abdominal cramping, AMS, eyes rolling upwards, and hypotension with systolic blood pressures in the 70s?80s/40s that promptly improved following IM epinephrine.  Diphenhydramine, famotidine, methylprednisolone, and a LR bolus was administered.  Following IM epinephrine administration, the patient's hemodynamic instability promptly improved along with her mentation.  Patient was monitored for 4.5 hours before being discharged home under the care of her partner with a EpiPen autoinjector kit.
Pt developed sore arm, body/muscle aches, fatigue, malaise, insomnia, sour stomach
we all got COVID; we all got COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (176890). The reporter is the patient.  A 58-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "we all got COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown, notes: we all got COVID.  Clinical course: the patient whole family got the 1st and 2nd dose as soon as it became available. Her husband has a heart condition, so they know it was very important to get the vaccine. They did not get COVID so they thought we were all good and still got the booster as soon as we could. We thought we were definitely good then, but then we all got COVID. The commercial emphasizes the fact that you can never be too careful, and it was our responsibility to ourselves and our community to take action and get the shot. We were all very surprised when we got the test done (we thought we had a common cold). Fortunately, the symptoms were fairly minor.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201068097 Same reporter/drug/event, different patient;
The pt received Varivax on 4/20/99 and on 11/30/01 the child broke out with a full blown case of chickenpox. Mom wanted your to be aware that the shot was not effective.
I developed a skin rash appearing on my arms and abdomen. It was burning and itchy. It was bright red with large blotch area with whelps in other areas. I had a few hives. I used Benadryl which helped until it wore off, the I used Zyrtec and it wore off. The rash spread everywhere from my head to my toes. I still have this rash. It has much improved but it is not gone. I went to the dermatologist and received a diagnosis.  She prescribed Zyrtec the standard dose. After the 14 days of treatment the rash reappeared. I went back on 12/15/2021 to the dermatologist. She then put me back on the Zyrtec for 8 weeks cause it was not resolved. Then I was on the medicine everyday for another 8 weeks. I am currently in the middle of the 2nd four weeks of the last 8 week round. The dermatologist suggested this is triggered by the vaccine, I have no other changes that would have created this.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 15Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 05Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 04Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Patient had no known allergies. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Results, notes: Product: COVID 19 Treatment; (05Jun2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Patient did not received other medication in 2 weeks. Treatment start date: 29May2022, Treatment stop date: 02Jun2022, After taking all the pills as directed and treating at home with very faint line for positive on the 3rd test the test lone was very bold and symptoms returned just as when first.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pain at the injection site just the first 24hours. Shivering during the first night.  Muscle pain especially on the shoulders the first night. Terrible headache for 48 hours, The 2nd day I got 1 pill of ibuprofen (600mg) and it has been decreasing. I feel better now.I still have mild headache, but I'm not taking ibuprofen anymore.
I received my second dose of the COVID vaccine on 3/5/21. The symptoms began on 3/7/21 with pain in my upper left arm. The next following night, I was awakened by sharp pains from the top of my left arm to my fingers. Even the back of my left arm is swollen. It even traveled down my back. I went to urgent care on Sunday 3/9/21 to see what had happened. A CNP said it seems musculoskeletal and the pain radiated from the injection site. I've taken Tylenol, Ibuprofen, been prescribed muscle relaxers and steroids to numb the pain but it doesn't work.  This is still occurring to this day.
Several large, patchy, red, slightly raised areas to upper rt. arm that are warm to touch. Patient had put vapor rub and lotion with ginger to upper rt arm when "rash" appeared.
That evening I had slight chills, low fever and body aches, which went away by the next day. The next morning, I had a severe tightening of the left side of my neck and shoulder, along with arm soreness. I saw my Physical Therapist and was told that it was a result of the vaccine. I was fine until I got the vertigo Friday evening. It came on really quickly and I've never experienced it before. I was okay the next morning with the exception of a headache, which lasted for about a month after that. My doctor offered shots for them, but I couldn't take them due to my current meds. I was told to come back if they continue.
Extreme fatigue, couldn?t get out of bed for 2 days, fever, chills and extremely red face. Heart racing, chest pain and tightness, hard to breathe. Nauseous, vomiting & diarrhea. Extreme migraine. I saw an allergic dr and had blood work done and eosinophils were highly elevated.  Now months after the events I?m having chronic wide spread pain and migraines. Chest pains and tightness intermittently.  Horrible allergies and breathing issues.
Vaccine was diluted with expired NS diluent (exp 11/1/21) and administered to the pt.
This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients) and NO ADVERSE EVENT (No adverse event) in a 23-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Sep-2022 at 3:12 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 24-Sep-2022 at 3:12 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients) and PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna and Bivalent vaccines have undergone several temperature excursions and may have been administered to patients).    Concomitant medication information was not provided.  The nurse reported about Moderna monovalent and bivalent vaccines that stored in the refrigerator that underwent several temperature excursions going back to Aug-2022 that were administered to patients.  The patient received first, second and third doses of Moderna COVID-19 vaccine via intramuscular route and site of administration was reported as deltoid muscle.  The patient received the fourth dose of Moderna COVID-19 bivalent vaccine on deltoid muscle.  No adverse reactions had been reported for the patient as per the reporter's knowledge.  No treatment information was provided.
I had severe itching after wards and woke up the next morning with hives all over my lower extremities. I took Benadryl for the hives and ibuprofen for the body aches. The hives lasted 6 days.
Information has been received from a female consumer with no pertinent medial history or allergies who on 28-FEB-2008, at 9:15 AM was vaccinated with a first dose of zoster vaccine live (Oka/Merck). Concomitant therapy included ascorbic acid and vitamin D (unspecified). On 28-FEB-2008, after running some errands and returning home at an unspecified time, the consumer noticed that her feet were cold, head was hot, and heart was racing and fluttering. She commented these symptoms resembled flu-like symptoms. As she was reporting this, at 12:40 PM, she reported that itching was developing. Medical attention was not sought. There were no laboratory tests or diagnostic studies performed. The outcome was reported as not recovered. No product quality complaint was involved. Additional information has been requested.
Narrative:  74yo with ADENOCARCINOMA OF THE ESOPHAGUS died peacefully at home on 11/6/2021 from cancer. Pt had received covid vaccines on 1/11/21 & 2/8/2021. This death is not related to covid vaccines.
Information has been received from a Licensed Vocational Nurse referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction/allergies reported. The patients were vaccinated with doses of improperly stored GARDASIL 9 with lot # L007560 (expired date 15-JUN-2017, dose and route were unknown) on 06-APR-2016, 12-APR-2016, 20-APR-2016, 13-MAY-2016 and 16-MAY-2016 and GARDASIL 9 with lot # L044475 (expired date 12-MAY-2017, dose and route were unknown) on unknown dates. The vaccine with lot # L007560 was exposed under 46.3 Fahrenheit (F) for 9 hours on 01-APR-2016, 46.5 F for 70 hours on 04-APR-2016 and 46.6 for 56 hours on 11-APR-2016. The vaccine with lot # L044475 was exposed under 46.6F for 144 hours on unknown dates. There was no previous excursion. No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
I had problems with my lymph nodes swelling; I am having a lot of problems with my left lymph nodes under my breast., They are really sore and painful; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (I had problems with my lymph nodes swelling) and LYMPH NODE PAIN (I am having a lot of problems with my left lymph nodes under my breast., They are really sore and painful) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and GERD. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Depression, OMEPRAZOLE for GERD.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (I had problems with my lymph nodes swelling) and LYMPH NODE PAIN (I am having a lot of problems with my left lymph nodes under my breast., They are really sore and painful). The patient was treated with ACETAMINOPHEN ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, LYMPHADENOPATHY (I had problems with my lymph nodes swelling) and LYMPH NODE PAIN (I am having a lot of problems with my left lymph nodes under my breast., They are really sore and painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-211470   (Patient Link).
rash on torso, thighs, h/a, swelling, bruising @ site;all sx started w/in 24hr;rash resolved w/o tx w/in 24hr;
That day there was a slightly raised red area about 1 1/2 inches in diameter. It lasted about a week and then I did not notice it for a few days.  On January 17 I noticed the area was starting to itch and what is a 2 inch raised red area. At times the red was more distinct around the outer edge.
unevaluable event; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (unevaluable event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced UNEVALUABLE EVENT (unevaluable event). At the time of the report, UNEVALUABLE EVENT (unevaluable event) outcome was unknown.            No concomitant medications were provided No treatment information was provided   This case was linked to US-MODERNATX, INC.-MOD-2021-130328 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-130328:same reporter
On 30AUG91 awake w/h/a, sore neck; On 2SEP91 had stomache even when drinking H20; c/o h/a, pressure in ears, t101; flu-like virus;
This spontaneous report was received from a vaccine coordinator and refers to multiple, unknown patients of unknown age and gender. No information about the patients' medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On unknown dates, the patients were vaccinated with improperly stored VARIVAX injection, lot# reported as M040139 with expiration date: 28-SEP-2018, lot# M028552 with expiration date: 07-JUN-2018, lot# M006729 with expiration date: 08-FEB-2018 (dose and route of administration were not reported). Multiple excursions had place that required the multiple excursion form to be sent, therefore temperature and time frame information was unknown. There was no previous temperature excursion. Digital data logger was used. No product quality complaint was involved. Additional information has been requested.
caller coughing, clearing her throat; shortness of breath; feeling extremely tired; This is a spontaneous report from a contactable consumer via the Medical Information Team. A 68-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at a single dose for COVID-19 immunization. Medical history included ongoing throat discomfort. The patient's concomitant medications were not reported. It was reported that the patient was experiencing symptoms of feeling extremely tired and shortness of breath; both on 23Jan2021. It was also reported that the patient was coughing. The outcome of the event shortness of breath was not recovered, recovering for tired while unknown for coughing.  Information on the lot/batch number has been requested.
Patient attended clinic stating she received her first shot in April 2021 and never went back for the second.  She had lost her vaccine card and thought her first shot was the Pfizer Covid Vaccine.  After injection was given, staff checked database and discovered that her first shot was actually the Johnson & Johnson vaccine.  She was monitored by staff for 30 minutes for side effects.  She did not experience any.  She was informed to seek medical care with any change in condition.
66 y/o male presents to the ED with generalized weakness, slurred speech, ataxia that started yesterday at 5:00pm while he was driving.  He had his second dose of the Covid vaccine at 4:30pm.  He woke this morning (6/30), still having symptoms, so his son brought him to the ED.  Diagnosis of stroke, acute CVA
One of our vaccinator did not dilute the product and gave all 6 doses; One of our vaccinator did not dilute the product and gave all 6 doses; swollen deltoid region; low grade fever for 24 hours only; This is a spontaneous report received from contactable reporter(s) (Physician) from medical information team.  A 12 year-old patient received bnt162b2 (BNT162B2), administration date 30Aug2021 (Batch/Lot number: unknown) at the age of 12 years as dose number unknown, 0.3ml single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PRODUCT PREPARATION ERROR (non-serious), OVERDOSE (non-serious) all with onset 30Aug2021, outcome "unknown" and all described as "One of our vaccinator did not dilute the product and gave all 6 doses"; PERIPHERAL SWELLING (non-serious) with onset 2021, outcome "recovered" (2021), described as "swollen deltoid region"; PYREXIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "low grade fever for 24 hours only".  Additional information: Health care professional reported that one of their vaccinator did not dilute the product and gave all 6 doses and gave 0.3 mL dose of undiluted vaccine. Health care professional consider the Pfizer product had a causal effect to the adverse events. The patient did not receive any vaccinations 4 weeks prior to BNT162B2. The patient did not perform any relevant tests. The patient had swollen deltoid region low grade fever for 24 hours only. No other adverse events signs were noted.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a nurse practitioner refers to a 5 year old female patient. The patient had on pertinent medical history and did not present any allergies. There was no information about the patient's concurrent conditions provided. On 09-NOV-2015, the patient was vaccinated with a dose of (Oka-Merck) PROQUAD subcutaneous injection, 0.5 ml, administered intramuscularly instead of subcutaneously in the left thigh, albumin status rHA, lot # L025204, expiration date 07-JAN-2017. Concomitant therapies included KINRIX vaccine, administered on the same day in different area of the left thigh. On an unknown date in approximately November 2015, the patient experienced a lump at the (Oka-Merck) PROQUAD injection site. The patient sought medical attention and was scheduled for an in-office visit. There was no treatment administered, since the patient had been seen by the time of the report. The outcome of injection site lump was reported as not recovered by the time of report. The relatedness between the injection site lump and the suspect vaccine was not reported. Additional information has been requested.